Leen Kawas Discusses Biotech Intellectual Property Protection Strategies

Successfully navigating a drug development cycle is a major undertaking. On average, the sequence takes over a decade to bring an innovative idea to the marketplace. The process involves drug candidate testing, multi-phase clinical trials, (ideally) FDA approval, and consistent monitoring after the drug hits the market. This intensive effort typically carries a $1 billion (or more) price tag.

To complicate the issue, the drug developer has no guarantee of success. Many drug candidates fall by the wayside as the development cycle proceeds. Only a small fraction of candidates make it to the FDA approval threshold. Even then, the developer could still receive a denial.

Originally published at https://www.sfexaminer.com on November 14, 2024.